Vanguard Group Inc Regenxbio Inc. Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025

A detailed history of Vanguard Group Inc transactions in Regenxbio Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,472,988 shares of RGNX stock, worth $28.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,472,988
Previous 2,985,952 16.31%
Holding current value
$28.6 Million
Previous $23.1 Million 7.58%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$5.92 - $8.7 $2.88 Million - $4.24 Million
487,036 Added 16.31%
3,472,988 $24.8 Million
Q4 2024

Feb 11, 2025
SELL
$7.23 - $11.56 $10 Million - $16 Million
-1,383,039 Reduced 31.66%
2,985,952 $23.1 Million
Q3 2024

Nov 13, 2024
SELL
$10.49 - $14.39 $7.81 Million - $10.7 Million
-744,791 Reduced 14.56%
4,368,991 $45.8 Million
Q2 2024

Aug 13, 2024
BUY
$11.51 - $21.53 $2.73 Million - $5.1 Million
236,901 Added 4.86%
5,113,782 $59.8 Million
Q1 2024

May 10, 2024
BUY
$12.17 - $24.61 $5.31 Million - $10.7 Million
436,043 Added 9.82%
4,876,881 $103 Million
Q4 2023

Feb 14, 2024
BUY
$12.89 - $20.82 $828,375 - $1.34 Million
64,265 Added 1.47%
4,440,838 $79.7 Million
Q3 2023

Nov 14, 2023
BUY
$16.46 - $19.99 $601,300 - $730,254
36,531 Added 0.84%
4,376,573 $72 Million
Q2 2023

Aug 14, 2023
BUY
$17.23 - $21.71 $396,651 - $499,785
23,021 Added 0.53%
4,340,042 $86.8 Million
Q1 2023

May 15, 2023
BUY
$18.08 - $24.55 $805,048 - $1.09 Million
44,527 Added 1.04%
4,317,021 $81.6 Million
Q4 2022

Feb 10, 2023
BUY
$20.4 - $24.73 $101,020 - $122,462
4,952 Added 0.12%
4,272,494 $96.9 Million
Q3 2022

Nov 14, 2022
BUY
$22.29 - $35.04 $339,231 - $533,273
15,219 Added 0.36%
4,267,542 $113 Million
Q2 2022

Aug 12, 2022
BUY
$19.35 - $35.04 $3.52 Million - $6.37 Million
181,861 Added 4.47%
4,252,323 $105 Million
Q1 2022

May 13, 2022
BUY
$24.62 - $34.31 $406,131 - $565,977
16,496 Added 0.41%
4,070,462 $135 Million
Q4 2021

Feb 14, 2022
BUY
$30.19 - $40.28 $1.35 Million - $1.8 Million
44,784 Added 1.12%
4,053,966 $133 Million
Q3 2021

Nov 12, 2021
BUY
$29.09 - $45.68 $1.9 Million - $2.99 Million
65,423 Added 1.66%
4,009,182 $168 Million
Q2 2021

Aug 13, 2021
BUY
$32.46 - $40.48 $128 Million - $160 Million
3,943,759 New
3,943,759 $153 Million

Others Institutions Holding RGNX

# of Institutions
181
Shares Held
45.4M
Call Options Held
64.9K
Put Options Held
103K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $356M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email